Bone marrow hematopoiesis is the process by which the marrow makes every type of blood cell: red cells, white cells, and platelets. It starts with a small population of hematopoietic stem cells (HSCs) that divide and mature along set pathways, guided by growth factors and by the marrow environment around them. When any step fails, the result is a recognizable clinical picture, from anemia to leukemia.
In this article I’ll cover where hematopoiesis happens, how the cell lineages branch, how the process is controlled, and what the mechanisms teach us at the bedside.
Where Does Hematopoiesis Happen?
Blood cell production moves around the body during development. In the early embryo it begins in the yolk sac, then shifts to the fetal liver and spleen, and by birth the bone marrow has taken over. For a closer look at the tissue itself, see our guide to the composition and function of bone marrow.
In young children, nearly all bones contain active red marrow. With age, marrow in the long bones is gradually replaced by fatty yellow marrow. In adults, active hematopoiesis is concentrated in the pelvis, spine, ribs, sternum, skull, and the ends of the femur and humerus. This is why the back of the pelvic bone is the usual site for a marrow biopsy.
The Mechanism: From Stem Cell to Mature Blood Cell
Hematopoietic Stem Cells
HSCs have two defining abilities. They can self-renew, making copies of themselves to keep the pool stable for life, and they are multipotent, able to give rise to every blood cell type. Most HSCs are quiet at any given moment, which protects them from damage and exhaustion.
Lineage Commitment
When an HSC divides to produce blood cells, its daughters become progenitor cells that gradually lose the ability to form other lineages. The two main branches are:
- Common myeloid progenitor: gives rise to red cells (erythroid lineage), platelets (via megakaryocytes), granulocytes (neutrophils, eosinophils, basophils), and monocytes.
- Common lymphoid progenitor: gives rise to B cells, T cells, and natural killer (NK) cells. T cells finish maturing in the thymus.
Each lineage then passes through recognizable stages under the microscope, such as the progression from proerythroblast to reticulocyte in the red cell line.
Key Growth Factors and Lifespans
| Cell type | Main regulating factor | Where the factor is made | Typical lifespan in blood |
|---|---|---|---|
| Red blood cells | Erythropoietin (EPO) | Kidneys, in response to low oxygen | About 120 days |
| Platelets | Thrombopoietin (TPO) | Mainly the liver | About 7 to 10 days |
| Neutrophils | Granulocyte colony-stimulating factor (G-CSF) | Many tissues, rising during infection | Hours in the circulation |
| Lymphocytes | Interleukins such as IL-7 | Marrow and thymic stromal cells | Days to years, depending on type |
These short lifespans explain why the marrow must work constantly. Every day it replaces vast numbers of red cells, platelets, and neutrophils.
The Bone Marrow Niche
HSCs do not float freely. They live in specialized locations called niches, close to blood vessels and the inner surface of bone. Supporting cells in the niche, including mesenchymal stromal cells, endothelial cells, and osteoblasts, release signals such as stem cell factor and the chemokine CXCL12 that keep stem cells anchored and regulate when they divide.
This niche has direct clinical relevance. Drugs that block the CXCL12 signal, or G-CSF itself, loosen the stem cells’ attachment and release them into the bloodstream. That is how stem cells are mobilized and collected for transplant without a surgical marrow harvest.
Clinical Insights: When Hematopoiesis Goes Wrong
Nearly every marrow disease can be traced to a particular step in this process. The main patterns are:
- Stem cell failure: In aplastic anemia and inherited syndromes such as Fanconi anemia, the stem cell pool is damaged or depleted, causing low counts in all lines.
- Single-lineage failure: Diamond-Blackfan anemia selectively affects red cell production because of defects in ribosome genes. Read more about Diamond-Blackfan anemia research and management.
- Nutrient or hormone deficiency: Iron, vitamin B12, and folate deficiency impair red cell production, and chronic kidney disease reduces EPO output.
- Clonal disorders: In myelodysplastic syndromes, stem cells acquire mutations and produce abnormal, ineffective cells. In leukemia, immature cells proliferate without maturing and crowd out normal production.
- Overproduction: Myeloproliferative neoplasms, such as polycythemia vera, drive excessive production of one or more lines.
- Marrow infiltration: Cancer spreading to bone, lymphoma, or fibrosis can replace normal marrow tissue.
Low platelet output in any of these settings raises bleeding risk, and some myeloproliferative conditions increase the risk of thrombosis. Both connect marrow disease to blood clotting disorders.
Extramedullary Hematopoiesis
When the marrow cannot keep up or is replaced, the liver and spleen can resume blood production, as they did before birth. This extramedullary hematopoiesis is seen in thalassemia and myelofibrosis and helps explain the enlarged spleen in these conditions.
How Hematopoiesis Is Assessed
A complete blood count and blood film are the first window into marrow output. The reticulocyte count is especially useful: a high count means the marrow is responding to blood loss or destruction, while a low count in the face of anemia points to a production problem.
When the cause remains unclear, bone marrow aspiration and biopsy show cellularity, the balance of lineages, maturation, and any abnormal cells. Flow cytometry, cytogenetics, and molecular testing on the sample identify clonal diseases.
Key Takeaways
- Hematopoiesis in adults takes place mainly in the red marrow of the axial skeleton.
- Hematopoietic stem cells self-renew and branch into myeloid and lymphoid lineages.
- Growth factors such as EPO, TPO, and G-CSF match production to the body’s needs.
- The marrow niche anchors stem cells, and disrupting it is the basis of stem cell mobilization for transplant.
- Marrow diseases map to specific failures: stem cell loss, single-lineage defects, deficiencies, clonal disorders, or infiltration.
To explore further, visit our guide to hematology and blood health, our overview of hematologic disorders, and our bone marrow guide.
Frequently Asked Questions
How long does it take the marrow to make a red blood cell?
Red cell development from a committed progenitor to a circulating reticulocyte takes about a week. Reticulocytes then mature into red cells in the blood within a day or two. That is why a reticulocyte response to iron or B12 treatment appears within days.
Can hematopoiesis happen outside the bone marrow in adults?
Yes. In conditions such as myelofibrosis or severe thalassemia, the liver and spleen can take up blood cell production again. This often enlarges these organs.
What controls how many blood cells the marrow makes?
Hormones and growth factors act as feedback signals. Low oxygen increases EPO from the kidneys, a low platelet mass leaves more TPO free to stimulate megakaryocytes, and infection raises G-CSF to boost neutrophils.
Does hematopoiesis slow with age?
The amount of active red marrow falls with age and the stem cell pool changes, so the marrow has less reserve under stress. Healthy older adults still maintain normal counts, so unexplained low counts should not be dismissed as simple aging.
